Abstract:Objective To investigate the clinico-pathological characteristics and diagnostic markers in esophageal carci-noma accompanied by neuroendocrine cell differentiation (E-NED).Methods The clinico-pathological data of 378 patients with poorly differentiated esophageal carcinoma from Jan.2008 to Dec.2013,including 349 without neuroen-docrine differentiation (E-NNED)and 29 with neuroendocrine differentiation (E-NED),were retrospectively analyzed. The expressions of synaptophysin (SYN),chromogranin A (CgA),neuron-specific enolase (NSE),neural cell adhe-sion molecule (CD56),protein gene product (PGP9.5 ),secretagogin (SCGN)and thyroid transcription factor 1 (TTF-1)in the esophageal carcinoma tissues of 29 patients with E-NED and 20 ones randomly selected from the 349 patients with E-NNED were detected using immunohistochemistry.Results There were no significant differences between the patients with E-NED and E-NNED in terms of the age,gender,length of lesion and other clinico-pathologi-cal factors.Except for TTF-1,the expressions of Syn,CgA,NSE,CD56,PGP9.5 and SCGN were significantly higher in patients with E-NED than those with E-NNED (P <0.05).The sensitivity,positive predictive value and <br> diagnostic accuracy were all higher in the combined detection of Syn and CD56,PGP9.5 or SCGN than Syn and CgA (P <0.05).There were no significant differences between the patients with E-NED and E-NNED regarding 1,2 and 3-year survival rates.Conclusion E-NED and E-NNED may be different pathological types of esophageal carcinoma. Both PGP9.5 and SCGN can be considered as the diagnostic markers of E-NED,and the combined detection of Syn and CD56,PGP9.5 or SCGN can improve the sensitivity and diagnostic accuracy.

Clinico-pathological characteristics and diagnostic biomarkers in patients with esophageal carcinoma accompanied by neuroendocrine cell differentiation